Quantum Biopharma Ltd. Subordinate Voting Shares Class B (DE:0K91)
NASDAQ:0K91
| Dec 22 | Dec 21 | Dec 20 | Aug 17 | |
|---|---|---|---|---|
| Income Statement | ||||
| Total Revenue | ||||
| Gross Profit | - | - | - | - |
| Operating Income | $ -27.48M | $ -33.81M | $ -30.60M | $ -19.37K |
| EBITDA | $ -22.57M | $ -29.09M | $ -24.32M | $ -19.37K |
| Net Income | $ -23.61M | $ -35.29M | $ -31.80M | $ -19.37K |
| Balance Sheet | ||||
| Cash & Short-Term Investments | $ ― | $ ― | $ ― | $ ― |
| Total Assets | $ 38.41M | $ 62.96M | $ 41.97M | $ 17.69K |
| Total Debt | $ 516.42K | $ 555.90K | $ 510.61K | $ 35.00K |
| Net Debt | $ -16.46M | $ -34.86M | $ -17.01M | $ 17.31K |
| Total Liabilities | $ 7.87M | $ 9.22M | $ 5.66M | $ 113.22K |
| Stockholders' Equity | $ ― | $ ― | $ ― | $ ― |
| Cash Flow | ||||
| Free Cash Flow | $ -29.10M | $ -21.25M | $ -19.13M | $ -21.11K |
| Operating Cash Flow | $ -28.33M | $ -20.75M | $ -19.13M | $ -21.11K |
| Investing Cash Flow | ||||
| Financing Cash Flow |